合并病理性骨折的上肢骨肿瘤穿刺活检结果分析
摘要点击次数: 1658   全文下载次数: 563   投稿时间:2020-08-18    
作者Author单位AddressE-Mail
邓志平 DENG Zhi-ping 积水潭医院骨肿瘤科, 北京 100035 Department of Orthopaedic Oncology Surgery, Jishuitan Hospital, Beijing 100035, China  
赵海涛 ZHAO Hai-tao 积水潭医院骨肿瘤科, 北京 100035 Department of Orthopaedic Oncology Surgery, Jishuitan Hospital, Beijing 100035, China  
孙扬 SUN Yang 积水潭医院骨肿瘤科, 北京 100035 Department of Orthopaedic Oncology Surgery, Jishuitan Hospital, Beijing 100035, China  
金韬 JIN Tao 积水潭医院骨肿瘤科, 北京 100035 Department of Orthopaedic Oncology Surgery, Jishuitan Hospital, Beijing 100035, China  
丁宜 DING Yi 积水潭医院病理科, 北京 100035  
牛晓辉 NIU Xiao-hui 积水潭医院骨肿瘤科, 北京 100035 Department of Orthopaedic Oncology Surgery, Jishuitan Hospital, Beijing 100035, China niuxiaohui@263.net 
期刊信息:《中国骨伤》2021年,第34卷,第6期,第527-530页
DOI:10.12200/j.issn.1003-0034.2021.06.009
基金项目:
中文摘要:

目的: 分析合并病理性骨折的上肢骨肿瘤穿刺活检结果,对可能的影响因素进行分析。

方法: 分析2015年1月至2019年12月收治的合并病理性骨折的上肢骨肿瘤患者,入选标准为患者行穿刺活检并接受了最终手术治疗,获得了穿刺活检及术后2次病理检查。符合入选标准的共77例,男55例,女22例;年龄5~88岁,中位年龄27岁;肿瘤位于肱骨67例,桡骨8例,尺骨2例。穿刺活检与最终诊断的疾病性质(良恶性)、诊断病名均一致为"正确",疾病性质正确而诊断病名不一致则为"支持",穿刺活检诊断的疾病性质错误则定为诊断"错误"。分析穿刺活检的准确性和影响因素。

结果: 穿刺活检正确63例(81.8%),支持14例(18.2%),错误0例。将患者的性别、年龄、部位、骨折是否移位、肿瘤的骨破坏类型(成骨或溶骨)、有无软组织肿块、病灶内有无液性区域对穿刺活检正确性的影响进行统计学分析,肿瘤有软组织肿块时穿刺活检正确率显著提高(P<0.05),病灶内有液性区域时正确率下降(P<0.05)。

结论: 穿刺活检对合并病理性骨折的上肢骨肿瘤诊断准确性高,活检取材时选择有软组织肿块区域能提高诊断准确性。
【关键词】病理性骨折  骨肿瘤  穿刺活检
 
Result analysis of percutaneous core needle biopsy for bone tumors in upper limbs with pathological fracture
ABSTRACT  

Objective: To analyze the results of percutaneous core needle biopsy for bone tumors in upper limbs with pathologic fracture and to find the possible factors that could impact the results.

Methods: The including criteria for this study was the patients who had received percutaneous core needle biopsy and definitive surgery,whose tumor was located at upper limb with pathologic fracture. From January 2015 to December 2019,seventy-seven patients were enrolled. There were 55 males and 22 females. The median age was 27 years old (range:5 to 88 years old). The tumor located at humerus in 67 cases,radius in 8 cases and ulna in 2 cases. If the pathologic diagnosis of core needle biopsy was the same with the definitive surgery,it was defined as "correct". If the pathologic diagnosis of biopsy for benign or malignant was right but the exact diagnostic name was not the same with definitive surgery,it was defined as "supportive". If the pathologic diagnosis of biopsy for benign or malignant was not correct,it was defined as "wrong". We retrospectively analyzed the accuracy and impact factors for core needle biopsy.

Results: The result was "correct" in 63 cases(81.8%),"supportive" in 14 cases(18.2%),and "wrong" in 0 cases. We analyzed the gender,age,location,fracture displacement,the destroyed type for bone tumor,soft tissue mass,fluid area in the tumor as the factors. The results showed the rate for "correct" was significantly higher when the tumor had soft tissue mass (P<0.05) and lower when the fluid area existed inside the tumor (P<0.05).

Conclusion: The accuracy of percutaneous core needle biopsy for upper limb bone tumor with pathologic is high and acceptable. The biopsy chosen the soft tissue mass area can increase the accuracy.
KEY WORDS  Pathological fracture  Bone tumor  Core needle biopsy
 
引用本文,请按以下格式著录参考文献:
中文格式:邓志平,赵海涛,孙扬,金韬,丁宜,牛晓辉.合并病理性骨折的上肢骨肿瘤穿刺活检结果分析[J].中国骨伤,2021,34(6):527~530
英文格式:DENG Zhi-ping,ZHAO Hai-tao,SUN Yang,JIN Tao,DING Yi,NIU Xiao-hui.Result analysis of percutaneous core needle biopsy for bone tumors in upper limbs with pathological fracture[J].zhongguo gu shang / China J Orthop Trauma ,2021,34(6):527~530
阅读全文  下载  查看/发表评论  下载PDF阅读器
关闭




版权所有:《中国骨伤》杂志社京ICP备12048066号-2  版权声明
地址:北京市东直门内南小街甲16号,100700
电话:010-64089487 传真:010-64089792 Email:zggszz@sina.com

京公网安备 11010102004237号